Variant report
Variant | esv1804750 |
---|---|
Chromosome Location | chr19:56267547-56281858 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:305)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:56268023-56268280 | A549 | lung: | n/a | chr19:56268130-56268143 |
2 | CEBPB | chr19:56277973-56278182 | K562 | blood: | n/a | chr19:56278128-56278141 |
3 | CEBPB | chr19:56268125-56268161 | Hela-S3 | cervix: | n/a | chr19:56268130-56268143 |
4 | CEBPB | chr19:56267971-56268186 | K562 | blood: | n/a | chr19:56268130-56268143 |
5 | CTCF | chr19:56277860-56278010 | HAc | cerebellar: | n/a | n/a |
6 | CTCF | chr19:56270569-56270612 | GM13976 | blood: | n/a | n/a |
7 | E2F4 | chr19:56270326-56270356 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | ELF1 | chr19:56271182-56271584 | K562 | blood: | n/a | chr19:56271419-56271432 |
9 | PBX3 | chr19:56277927-56278096 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr19:56274116-56274147 | A549 | lung: | n/a | n/a |
11 | SPI1 | chr19:56277792-56278107 | GM12878 | blood: | n/a | n/a |
12 | STAT3 | chr19:56267962-56268162 | MCF10A-Er-Src | breast: | n/a | chr19:56268133-56268141 |
13 | STAT3 | chr19:56276461-56276799 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | TBP | chr19:56270440-56270473 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56270729-56270779 | PrEC | prostate: | n/a |
2 | chr19:56270498-56270548 | HRPEpiC | eye: | n/a |
3 | chr19:56269246-56269296 | HRE | kidney: | n/a |
4 | chr19:56270729-56270779 | CMK | blood: | n/a |
5 | chr19:56270498-56270548 | HPAEpiC | pulmonary alveolar: | n/a |
6 | chr19:56269259-56269309 | ProgFib | skin: | n/a |
7 | chr19:56270498-56270548 | CMK | blood: | n/a |
8 | chr19:56274428-56274478 | RPTEC | kidney: | n/a |
9 | chr19:56269259-56269309 | HCM | heart: | n/a |
10 | chr19:56270729-56270779 | NH-A | brain: | n/a |
11 | chr19:56269259-56269309 | HUVEC | blood vessel: | n/a |
12 | chr19:56269259-56269309 | SAEC | small airway: | n/a |
13 | chr19:56269246-56269296 | AG09309 | skin: | n/a |
14 | chr19:56274428-56274478 | LNCaP | prostate: | n/a |
15 | chr19:56270498-56270548 | Hela-S3 | cervix: | n/a |
16 | chr19:56269246-56269296 | LNCaP | prostate: | n/a |
17 | chr19:56270729-56270779 | PFSK-1 | brain: | n/a |
18 | chr19:56270729-56270779 | NB4 | blood: | n/a |
19 | chr19:56270498-56270548 | H1-hESC | embryonic stem cell: | embryo |
20 | chr19:56269246-56269296 | MCF10A-Er-Src | breast: | n/a |
21 | chr19:56274428-56274478 | HUVEC | blood vessel: | n/a |
22 | chr19:56274428-56274478 | HAEpiC | amniotic membrane: | n/a |
23 | chr19:56269259-56269309 | AG04450 | lung: | fetal |
24 | chr19:56269246-56269296 | NH-A | brain: | n/a |
25 | chr19:56269246-56269296 | ProgFib | skin: | n/a |
26 | chr19:56269259-56269309 | HNPCEpiC | eye: | n/a |
27 | chr19:56274428-56274478 | HCT-116 | colon: | n/a |
28 | chr19:56270498-56270548 | MCF-7 | breast: | n/a |
29 | chr19:56270729-56270779 | HEEpiC | esophagus: | n/a |
30 | chr19:56270729-56270779 | K562 | blood: | n/a |
31 | chr19:56269259-56269309 | AoSMC | blood vessel: | n/a |
32 | chr19:56269246-56269296 | SK-N-MC | brain: | n/a |
33 | chr19:56269259-56269309 | CMK | blood: | n/a |
34 | chr19:56270498-56270548 | A549 | lung: | n/a |
35 | chr19:56270498-56270548 | HEK293 | kidney: | embryo |
36 | chr19:56274428-56274478 | PrEC | prostate: | n/a |
37 | chr19:56269259-56269309 | HRPEpiC | eye: | n/a |
38 | chr19:56269259-56269309 | Caco-2 | colon: | n/a |
39 | chr19:56269246-56269296 | T-47D | breast: | n/a |
40 | chr19:56270729-56270779 | BJ | skin: | n/a |
41 | chr19:56269246-56269296 | HUVEC | blood vessel: | n/a |
42 | chr19:56270498-56270548 | SKMC | muscle: | n/a |
43 | chr19:56270729-56270779 | BE2_C | brain: | n/a |
44 | chr19:56270729-56270779 | SAEC | small airway: | n/a |
45 | chr19:56270729-56270779 | AG10803 | skin: | n/a |
46 | chr19:56270729-56270779 | HCPEpiC | choroid plexus: | n/a |
47 | chr19:56269259-56269309 | NH-A | brain: | n/a |
48 | chr19:56269246-56269296 | HRCEpiC | kidney: | n/a |
49 | chr19:56269246-56269296 | K562 | blood: | n/a |
50 | chr19:56270498-56270548 | AG10803 | skin: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AL1 | TF binding region |
RFPL4A | TF binding region |
RFPL4AL1 | CpG island |
RFPL4A | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8106001 | chr19:56267547-56267548 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs574349141 | chr19:56267549-56267550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540149855 | chr19:56267553-56267554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12151007 | chr19:56267561-56267562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs2616953 | chr19:56267570-56267571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576803345 | chr19:56267603-56267604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs8107031 | chr19:56267696-56267697 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs562645281 | chr19:56267699-56267700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs8106255 | chr19:56267726-56267727 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs368070105 | chr19:56267745-56267746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542397103 | chr19:56267756-56267757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575670843 | chr19:56267759-56267760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs8106481 | chr19:56267804-56267805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527955141 | chr19:56267810-56267811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113808757 | chr19:56267828-56267829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140070552 | chr19:56267839-56267840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533403726 | chr19:56267850-56267851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550003402 | chr19:56267863-56267864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540692778 | chr19:56267891-56267892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561061789 | chr19:56267892-56267893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549553950 | chr19:56267900-56267901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202004675 | chr19:56267901-56267902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570084644 | chr19:56267914-56267915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535561253 | chr19:56267923-56267924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554306646 | chr19:56267966-56267967 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs77863317 | chr19:56267975-56267976 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs567933372 | chr19:56267993-56267994 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs192900451 | chr19:56267994-56267995 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs112689005 | chr19:56268001-56268002 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs112165336 | chr19:56268008-56268009 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs185103383 | chr19:56268029-56268030 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs539467920 | chr19:56268040-56268041 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs8109283 | chr19:56268045-56268046 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs62126987 | chr19:56268048-56268049 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs541962535 | chr19:56268052-56268053 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs569249539 | chr19:56268060-56268061 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs562238778 | chr19:56268074-56268075 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs2547255 | chr19:56268083-56268084 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs544728906 | chr19:56268086-56268087 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs5028530 | chr19:56268101-56268102 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs564844735 | chr19:56268103-56268104 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs386811101 | chr19:56268106-56268107 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs374840956 | chr19:56268107-56268108 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs74181753 | chr19:56268112-56268113 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs8109382 | chr19:56268117-56268118 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs549097361 | chr19:56268132-56268133 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs200491013 | chr19:56268136-56268137 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs140113273 | chr19:56268144-56268145 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs533779481 | chr19:56268173-56268174 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs113234402 | chr19:56268176-56268177 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56265800-56268200 | Weak transcription | Liver | Liver |
2 | chr19:56267000-56268200 | Weak transcription | Pancreas | Pancrea |
3 | chr19:56268000-56269800 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr19:56268200-56268400 | ZNF genes & repeats | Liver | Liver |
5 | chr19:56268200-56268400 | Enhancers | Pancreas | Pancrea |
6 | chr19:56268400-56272600 | Weak transcription | Liver | Liver |
7 | chr19:56269800-56270200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr19:56270200-56271800 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr19:56272600-56272800 | Active TSS | Liver | Liver |
10 | chr19:56277000-56279600 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr19:56278000-56278200 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
12 | chr19:56279600-56280000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
13 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |